Sample characteristic | Pre-implementation n (%) | Post-implementation n (%) | p-value * |
---|---|---|---|
Female / male | 52 (54.2) / 44 (45.8) | 39 (40.6) / 57 (59.4) | 0.08 |
Age | |||
 0–3 months | 22 (22.9) | 17 (17.7) | 0.16 |
 4–11 months | 4 (4.2) | 11 (11.5) | |
 1–3 years | 20 (20.8) | 23 (24.0) | |
 4–6 years | 14 (14.6) | 18 (18.8) | |
 7–11 years | 16 (16.7) | 17 (17.7) | |
 12–16.9 years | 20 (20.8) | 10 (10.4) | |
Most responsible diagnosis a | |||
 Respiratory | 23 (24.0) | 26 (27.1) | 0.24 |
 Gastrointestinal | 10 (10.4) | 19 (19.8) | |
 Hyperbilirubinemia | 10 (10.4) | 8 (8.3) | |
 Other diagnosis | 53 (55.2) | 43 (44.8) | |
Discharge disposition from ED | |||
 Transferred to higher level of care | 37 (38.5) | 22 (22.9) | 0.03 |
 Admitted internally | 59 (61.5) | 74 (77.1) | |
CTAS level | |||
 CTAS 1 | 7 (7.3) | 10 (10.4) | 0.05 |
 CTAS 2 | 44 (45.8) | 43 (44.8) | |
 CTAS 3 | 40 (41.7) | 28 (29.2) | |
 CTAS 4 | 5 (5.2) | 15 (15.6) |